Chemotherapy ErbB-2 overexpression

The more aggressive phenotype of ErbB-2-overexpressing cells, both in clinical and laboratory settings, implied that the level of ErbB-2 is a predictive factor. Indeed, the reports reviewed next suggest some correlation with response to adjuvant hormonal and chemotherapy. 

---